UK’s MHRA To Use AI In Regulatory Review Process & RWD Analysis

The MHRA’s regulatory strategy on AI outlines key areas where this technology could be used to improve the agency’s own processes, and says that the use of AI to develop drugs will not change the questions it asks companies.